Inhaled Nitric Oxide Plus Iloprost in the Setting of Post-Left Assist Device Right Heart Dysfunction Theofani Antoniou, MD, PhD, Christos Prokakis, MD, PhD, Georgios Athanasopoulos, MD, PhD, Apostolos Thanopoulos, MD, Panagiota Rellia, MD, Dimitrios Zarkalis, MD, Nektarios Kogerakis, MD, Efstratios N. Koletsis, MD, PhD, Andreas Bairaktaris, MD The Annals of Thoracic Surgery Volume 94, Issue 3, Pages 792-798 (September 2012) DOI: 10.1016/j.athoracsur.2012.04.046 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Treatment protocol for patients with congestive heart failure undergoing mechanical circulatory support. (LVAD = left ventricular assist device; LVFRI = left ventricular flow rate index; RV = right ventricle; RVD = right ventricular dysfunction.) The Annals of Thoracic Surgery 2012 94, 792-798DOI: (10.1016/j.athoracsur.2012.04.046) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Mean pulmonary artery pressure/mean arterial pressure (MPAP/MAP) versus time. The Annals of Thoracic Surgery 2012 94, 792-798DOI: (10.1016/j.athoracsur.2012.04.046) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Mean pulmonary vascular resistance/systemic vascular resistance (PVR/SVR) ratio versus time. The Annals of Thoracic Surgery 2012 94, 792-798DOI: (10.1016/j.athoracsur.2012.04.046) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions